175 related articles for article (PubMed ID: 10720935)
21. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
22. Evidence that endoplasmic reticulum (ER)-associated degradation of cystic fibrosis transmembrane conductance regulator is linked to retrograde translocation from the ER membrane.
Xiong X; Chong E; Skach WR
J Biol Chem; 1999 Jan; 274(5):2616-24. PubMed ID: 9915789
[TBL] [Abstract][Full Text] [Related]
23. Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR.
Rubenstein RC; Zeitlin PL
Am J Physiol Cell Physiol; 2000 Feb; 278(2):C259-67. PubMed ID: 10666020
[TBL] [Abstract][Full Text] [Related]
24. Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.
Estabrooks S; Brodsky JL
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936842
[TBL] [Abstract][Full Text] [Related]
25. Biosynthesis of cystic fibrosis transmembrane conductance regulator.
Pranke IM; Sermet-Gaudelus I
Int J Biochem Cell Biol; 2014 Jul; 52():26-38. PubMed ID: 24685677
[TBL] [Abstract][Full Text] [Related]
26. Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants.
Sun F; Zhang R; Gong X; Geng X; Drain PF; Frizzell RA
J Biol Chem; 2006 Dec; 281(48):36856-63. PubMed ID: 16954204
[TBL] [Abstract][Full Text] [Related]
27. Redundancy of mammalian proteasome beta subunit function during endoplasmic reticulum associated degradation.
Oberdorf J; Carlson EJ; Skach WR
Biochemistry; 2001 Nov; 40(44):13397-405. PubMed ID: 11683650
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic restoration of delta F508 CFTR-mediated chloride current.
Zeitlin PL
Kidney Int; 2000 Mar; 57(3):832-7. PubMed ID: 10720936
[TBL] [Abstract][Full Text] [Related]
29. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
[TBL] [Abstract][Full Text] [Related]
30. Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622.
Norez C; Bilan F; Kitzis A; Mettey Y; Becq F
J Pharmacol Exp Ther; 2008 Apr; 325(1):89-99. PubMed ID: 18230692
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications.
Vij N; Fang S; Zeitlin PL
J Biol Chem; 2006 Jun; 281(25):17369-17378. PubMed ID: 16621797
[TBL] [Abstract][Full Text] [Related]
32. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
[TBL] [Abstract][Full Text] [Related]
33. Macromolecular interactions and ion transport in cystic fibrosis.
Guggino WB; Banks-Schlegel SP
Am J Respir Crit Care Med; 2004 Oct; 170(7):815-20. PubMed ID: 15447951
[TBL] [Abstract][Full Text] [Related]
34. Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines.
Varga K; Jurkuvenaite A; Wakefield J; Hong JS; Guimbellot JS; Venglarik CJ; Niraj A; Mazur M; Sorscher EJ; Collawn JF; Bebök Z
J Biol Chem; 2004 May; 279(21):22578-84. PubMed ID: 15066992
[TBL] [Abstract][Full Text] [Related]
35. Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.
Belcher CN; Vij N
Curr Mol Med; 2010 Feb; 10(1):82-94. PubMed ID: 20205681
[TBL] [Abstract][Full Text] [Related]
36. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
[TBL] [Abstract][Full Text] [Related]
37. VCP/p97 AAA-ATPase does not interact with the endogenous wild-type cystic fibrosis transmembrane conductance regulator.
Goldstein RF; Niraj A; Sanderson TP; Wilson LS; Rab A; Kim H; Bebok Z; Collawn JF
Am J Respir Cell Mol Biol; 2007 Jun; 36(6):706-14. PubMed ID: 17272822
[TBL] [Abstract][Full Text] [Related]
38. Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism.
Gelman MS; Kopito RR
Methods Mol Biol; 2003; 232():27-37. PubMed ID: 12840537
[No Abstract] [Full Text] [Related]
39. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation.
Zaman K; McPherson M; Vaughan J; Hunt J; Mendes F; Gaston B; Palmer LA
Biochem Biophys Res Commun; 2001 Jun; 284(1):65-70. PubMed ID: 11374871
[TBL] [Abstract][Full Text] [Related]
40. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners.
Li C; Naren AP
Pharmacol Ther; 2005 Nov; 108(2):208-23. PubMed ID: 15936089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
